Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Sensus Healthcare, Inc. SRTS

Healthcare  —  Medical Devices
2.94 0.03 1.03% as of 25 Sep
Market cap
$47.9M
P/E
0.0×
Insider Buys (last 12m)
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Sensus Healthcare, Inc. (SRTS) Business Profile

Updated before January 2025

Company Overview

Sensus Healthcare, Inc. (NASDAQ: SRTS) is a medical device company specializing in non-invasive treatment solutions for oncological and dermatological conditions. Founded in 2010 and headquartered in Boca Raton, Florida, Sensus Healthcare has established itself as a leader in the development and commercialization of superficial radiation therapy (SRT) systems. The company was co-founded by Joseph C. Sardano, who serves as the Chairman and Chief Executive Officer, and Stephen Cohen, who has played a pivotal role in the company’s growth. Sensus Healthcare’s mission is to provide innovative, patient-centric solutions that improve the quality of life for individuals suffering from non-melanoma skin cancer and other skin conditions.

The company operates with a strong focus on research and development, ensuring that its products remain at the forefront of medical technology. With a dedicated team of professionals and a robust distribution network, Sensus Healthcare has expanded its reach to healthcare providers and patients globally.

Core Business Segments

Superficial Radiation Therapy (SRT) Systems

Sensus Healthcare’s flagship product line is its Superficial Radiation Therapy (SRT) systems, which are designed to treat non-melanoma skin cancers, such as basal cell carcinoma and squamous cell carcinoma, as well as keloid scars. The key products in this category include:

  • SRT-100™: A compact and cost-effective system designed for dermatologists and oncologists to treat non-melanoma skin cancers and keloids.
  • SRT-100 Vision™: An advanced version of the SRT-100, featuring high-frequency ultrasound imaging for precise treatment planning and delivery.
  • SRT-100 Plus™: A versatile system offering enhanced features for improved patient outcomes.

These systems provide a non-invasive alternative to surgical procedures, reducing patient discomfort and recovery time while maintaining high efficacy rates.

Keloid Treatment Solutions

Sensus Healthcare has also positioned itself as a leader in the treatment of keloid scars. The company’s SRT systems are FDA-cleared for this indication, offering patients a non-surgical option to address these often-painful and unsightly scars. This segment has seen significant growth due to the increasing demand for effective keloid treatments.

Service and Maintenance

In addition to its product offerings, Sensus Healthcare provides comprehensive service and maintenance programs for its SRT systems. These services ensure that healthcare providers can operate their equipment efficiently and with minimal downtime, enhancing the overall customer experience.

Business Model

Sensus Healthcare operates on a business model that integrates product sales, service contracts, and consumables to generate revenue. The company’s primary revenue streams include:

  1. Product Sales: The sale of SRT systems to dermatologists, oncologists, and other healthcare providers forms the backbone of Sensus Healthcare’s revenue.
  2. Service Contracts: The company offers maintenance and support services for its systems, providing a recurring revenue stream.
  3. Consumables: Sensus Healthcare also generates revenue through the sale of consumables required for the operation of its SRT systems.

By combining innovative products with robust support services, Sensus Healthcare ensures long-term customer satisfaction and loyalty.

Strategic Direction

Sensus Healthcare is committed to expanding its product portfolio and geographic reach to drive future growth. Key strategic initiatives include:

  • Product Innovation: The company continues to invest in research and development to enhance its existing products and develop new solutions for unmet medical needs.
  • Geographic Expansion: Sensus Healthcare aims to increase its presence in international markets, particularly in regions with high incidences of non-melanoma skin cancer and keloids.
  • Sustainability Goals: The company is exploring ways to make its operations more sustainable, including reducing waste and improving energy efficiency in its manufacturing processes.
  • New Product Categories: Sensus Healthcare is evaluating opportunities to expand into adjacent markets, such as other forms of radiation therapy and dermatological treatments.

Competitive Landscape

Sensus Healthcare operates in a competitive market, facing competition from both established players and emerging companies. Key competitors include:

  • Varian Medical Systems: A leader in radiation therapy and oncology solutions.
  • Elekta AB: A global provider of precision radiation therapy equipment.
  • Accuray Incorporated: Known for its innovative radiation therapy systems.
  • Aesthetic and Dermatology Device Companies: Companies offering alternative treatments for skin conditions, such as laser-based systems.

Despite the competition, Sensus Healthcare differentiates itself through its focus on non-invasive solutions and its commitment to customer support.

Risk Factors

Sensus Healthcare faces several risks that could impact its business operations and financial performance. These include:

  • Market Dependence: The company’s revenue is heavily reliant on the sales of its SRT systems, making it vulnerable to market fluctuations.
  • Regulatory Challenges: Changes in healthcare regulations or delays in obtaining regulatory approvals could affect product launches and sales.
  • Supply Chain Disruptions: Dependence on third-party suppliers for components exposes the company to potential supply chain disruptions.
  • Competition: Intense competition from larger, well-established companies could impact market share and pricing.

Recent Developments

Sensus Healthcare has made significant strides in recent years, including:

  • Launch of SRT-100 Vision™: The introduction of this advanced system has been well-received by healthcare providers, enhancing the company’s product portfolio.
  • Expansion into New Markets: The company has entered new geographic markets, increasing its global footprint.
  • COVID-19 Impact: While the pandemic posed challenges, Sensus Healthcare adapted by implementing virtual training programs and enhancing its digital marketing efforts.

Investment Considerations

Strengths

  • Innovative Product Portfolio: Sensus Healthcare’s focus on non-invasive solutions sets it apart from competitors.
  • Growing Market Demand: The increasing prevalence of non-melanoma skin cancer and keloids drives demand for the company’s products.
  • Strong Leadership: Experienced leadership ensures strategic decision-making and execution.

Risks

  • Market Dependence: Heavy reliance on SRT systems for revenue.
  • Regulatory Risks: Potential delays in product approvals.
  • Competition: Intense competition from larger players.

Conclusion

Sensus Healthcare, Inc. is a pioneering company in the field of non-invasive medical treatments, with a strong focus on innovation and customer satisfaction. While the company faces challenges such as market dependence and competition, its commitment to product development and geographic expansion positions it well for future growth. With a growing market for non-melanoma skin cancer and keloid treatments, Sensus Healthcare is poised to maintain its leadership position and deliver value to its stakeholders.